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Understanding the transcriptional mechanisms that underlie pancreas for-
mation is central to the efforts to develop novel regenerative therapies for 
type 1 diabetes. Recently, mutations in the transcription factor GATA6 were 
unexpectedly shown to be the most common cause of human pancreas agen-
esis. In this issue of the JCI, Carrasco et al. and Xuan et al. investigate the role 
of Gata6 and its paralogue Gata4 in mouse embryonic pancreas and show 
that GATA factors are essential regulators of the proliferation, morphogen-
esis, and differentiation of multipotent pancreatic progenitors.
Type 1 diabetes results from autoimmune 
destruction of insulin-producing β cells. 
The major goal of current research efforts 
to reverse this disease is focused on learn-
ing how to generate new β cells to replace 
those that have been destroyed while at 
the same time blocking the autoimmune 
process. This challenge has fueled intense 
research to uncover the extracellular sig-
nals and transcriptional regulators that 
promote the generation of β cells during 
embryonic development (1–3). Proof-of-
concept experiments have shown that this 
type of knowledge can indeed be exploited 
to derive insulin-producing cells from mul-
tipotent cells in vitro (4) or through trans-
differentiation of somatic cells (5).
One of the critical stages of the devel-
opmental process that leads to β cell dif-
ferentiation is the formation and orderly 
expansion of pancreatic multipotent pro-
genitors. The latter originate from the 
foregut endoderm at around E8.5 in mice 
(6), and prior to 26 days post conception 
(dpc) in humans (ref. 7 and Figure 1). 
Nearly two decades ago, mouse genetic 
knockout experiments first proved that 
Pdx1 is essential for the expansion of the 
early pancreatic bud (8, 9). Since then, 
numerous transcription factors have been 
shown to be essential at this initial devel-
opmental stage, including Pdx1, Ptf1a, 
Mnx1, Sox9, and Hnf1b (3). In mice, only 
homozygous null mutations of these fac-
tors (either germline, chimeric, or condi-
tional) have revealed a pancreatic pheno-
type. For some transcription factors, such 
as Foxa1/2, Onecut1, or Nkx6.1, critical 
regulatory roles have been uncovered by 
the complete inactivation of more than 
one gene, reflecting a degree of functional 
redundancy (10–12). Although most of 
these discoveries have relied on mouse 
genetics, mutations in PDX1, PTF1A, and 
HNF1B have also been identified in human 
patients with monogenic diabetes and 
pancreatic aplasia or hypoplasia, consis-
tent with the notion that pancreatic devel-
opmental programs are fundamentally 
conserved in humans and mice (3).
Human genetics uncovers a key 
pancreatic regulator
Genome sequencing technologies have 
recently provided a major unexpected dis-
covery in this field. Allen et al. examined 
27 human patients who had neonatal dia-
betes due to pancreas agenesis and found 
that only one had a homozygous mutation 
in a known pancreatic regulator. An exome 
sequencing strategy revealed that 15 of the 
remaining patients had heterozygous loss 
of function mutations in the gene encod-
ing the zinc finger transcription factor 
GATA6 (13). Patients also had develop-
mental cardiac defects, in some cases mild, 
consistent with earlier reports of GATA6 
mutations causing cardiac outflow defects. 
Several patients with mutations had endo-
derm developmental abnormalities, includ-
ing thyroid, pituitary, gut, and biliary tract 
defects. In short, most humans with pan-
creatic agenesis have mutations in a gene 
that had so far been largely left off the 
radar screen in the pancreas development 
field. Intriguingly, another case report 
described a mutation in the paralogue 
GATA4 in a single patient with pancreatic 
agenesis and a cardiac malformation (14). 
The human genetics findings therefore 
establish that GATA6 (and less conclu-
sively GATA4) is an essential regulator of 
pancreas development, although they do 
not shed light on the underlying molecular 
mechanism, nor do they define the precise 
cell types or developmental stages in which 
the essential role takes place.
Modeling GATA function in mice
In this issue of the JCI, Carrasco et al. and 
Xuan et al. (15, 16) report two mouse 
genetic studies that define a key regulatory 
role of Gata6 and Gata4 in pancreas devel-
opment. In both reports, the two Gata 
genes were inactivated in embryonic mul-
tipotent pancreatic progenitors using Cre/
LoxP technology. Conditional mutations 
were required because germline homozy-
gote null mutations cause early embry-
onic lethality, whereas heterozygote mice 
have no known pancreatic defect (17, 18). 
Unexpectedly, the inactivation of either 
Gata4 or Gata6 in pancreatic progenitors 
did not cause severe pancreatic defects. 
However, the simultaneous deletion of 
both factors caused a major reduction in 
the pancreatic size related to a severe block 
in the proliferation of multipotent pancre-
atic progenitors. Furthermore, there was 
abnormal branching morphogenesis and 
a severe defect in differentiation, includ-
ing failure to separate into peripheral 
acinar-committed progenitors and central 
endocrine-committed progenitors. Xuan et 
al. performed an additional experiment in 
which they deleted Gata genes in the endo-
derm prior to the appearance of the pan-
creas and again found that the pancreatic 
bud was formed, yet failed to expand (16). 
This means that, at least with the genetic 
tools that were used in these studies, there 
is no indication that GATA factors in fore-
gut endoderm cells have a cell-autonomous 
role in pancreas specification. Instead, 
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the data show that Gata4 and Gata6 play 
essential functions in embryonic pancre-
atic progenitors.
Although the most severe phenotypes 
result from loss of GATA function in 
pancreatic embryonic multipotent pro-
genitors, the studies also suggest that they 
may have important functions beyond 
this stage. For example, Carrasco et al. 
show that mice with pancreatic deletions 
of both Gata4 alleles and one Gata6 allele 
have severe loss of acinar cells (15). Another 
recent report has now shown that mice in 
which only Gata6 is completely inactivated 
in pancreatic progenitors are histologically 
normal at birth, but eventually develop a 
severe loss of acinar cells (19). Thus, GATA 
factors appear to exert distinct essential 
functions throughout different steps of 
pancreatic cell formation.
Why does GATA6 haploinsufficiency 
cause pancreatic agenesis in humans, 
whereas in mice, three or four GATA alleles 
need to be deleted to elicit a severe pan-
creatic phenotype? It is important to note 
that haploinsufficiency of transcription 
factor genes is not uncommon in human 
developmental disorders. In pancreatic 
disease, heterozygous loss-of-function 
mutations in HNF1B, HNF4A, and HNF1A 
genes cause diabetes in humans but not in 
mice (2). The exact reason for this mouse-
specific tolerance to haploinsufficiency of 
transcription factor genes has not been 
clarified. One candidate explanation is 
that some developmental stages in human 
last weeks longer than in mice. This could 
increase the likelihood that there are del-
eterious consequences from fluctuations 
in transcriptional levels that are not suf-
ficiently buffered by the presence of the 
other healthy allele. In the case of GATA6 
and GATA4, four alleles are in play. It is 
possible that the gene expression patterns 
of these two genes exhibit greater overlap at 
critical steps of early pancreas development 
in mouse versus human embryos, thus ren-
dering mice more resilient to genetic per-
turbations of a single GATA gene.
GATA factors regulate Pdx1
How do GATA factors exert their essen-
tial functions in pancreatic progenitors? 
GATA4 and GATA6 transcription factors 
have been shown to initiate developmental 
programming steps important for heart, 
gut, and liver development (17, 18). The 
current studies now show that GATA fac-
tors are important for the activation of 
Pdx1, which encodes another essential pan-
creatic developmental transcription factor 
(8, 9). Carrasco et al. created a transgenic 
mouse containing the upstream sequence 
of Pdx1 linked to a reporter and showed 
that deleting GATA-binding sites prevent-
ed the activation of the reporter in early 
embryonic multipotent pancreatic progen-
itors (15). This is consistent with the obser-
vation that Pdx1 expression is reduced in 
pancreatic progenitors of mutant mice, 
although it is slightly at odds with the 
experiments from Xuan et al., suggesting 
that GATA factors are not required in the 
endoderm to initiate the expression of Pdx1 
and the inception of pancreatic buds (16). 
It is possible, however, that enhancers of 
the Pdx1 gene that were not included in the 
transgenic construct and do not require 
GATA factors are sufficient to initiate Pdx1 
expression in foregut endoderm.
An organ-building tool kit
Gata6 and Gata4 are broadly expressed in 
endodermal and mesodermal lineages (20), 
in contrast with Pdx1 and Ptf1a, which are 
expressed in the pancreatic anlage and only 
few other embryonic cell types. Early studies 
showing that Pdx1 and Ptf1a have a selective 
expression pattern coupled with the fact 
that their knockout mice develop pancreas 
agenesis suggested that these two factors 
might work as master regulators of pancre-
as organogenesis (8, 21). It has now become 
clear, however, that pancreatic multipotent 
progenitors require a larger transcription 
factor tool kit, which the current work sug-
gests includes GATA4 and GATA6 in addi-
tion to PDX1, PTF1A, MNX1, ONECUT1, 
NKX6.1/NKX6.2, FOXA1/2, SOX9, and 
HNF1B (Figure 1). The inactivation of each 
one of these factors, either alone or in com-
bination, disrupts the progenitor program 
and thereby blocks pancreas development. 
Due to the combinatorial nature of tran-
scription factor function, it is the unique 
coalescence of factors that drives the pan-
creatic progenitor program, and therefore it 
does not matter whether a particular tran-
scription factor is more or less specific to 
the pancreatic lineage. Based on the genetic 
findings, we can surmise that all of these 
factors are required to bind to regulatory 
elements that control the transcription of 
genes that are important for all of the things 
that pancreatic multipotent progenitors 
need to do, namely to proliferate, undergo 
morphogenetic changes, and differentiate. 
This likely also involves conferring respon-
siveness to the extracellular signals that 
promote developmental processes. In short, 
an interesting combination of mouse and 
human genetics has provided an inventory 
of the key transcription factors for pancreas 
organogenesis. This represents an impor-
tant step in untangling the mechanisms of 
pancreas organogenesis, which can now be 
pursued with novel technologies to manipu-
late whole animal and in vitro human mod-
els and to analyze them with genome-scale 
tools. Knowledge of the components of this 
developmental tool kit and the instructions 
followed are invaluable in allowing us to 
recapitulate the process for cell replacement 
therapies. The studies from Carrasco et al. 
and Xuan et al. provide a landmark advance 
in this direction (15, 16).
Figure 1
Representation of early pancreatic development. At approximately E9 in the mouse, pancreatic 
progenitors form dorsal and ventral buds off of the developing gut tube. Just a few days later, 
these multipotent progenitors give rise to a branched structure in which the tips are committed to 
an acinar cell fate, and the trunk contains duct-endocrine progenitors. The box lists transcription 
factors required for this remarkable transition.
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Defending the cornea  
with antibacterial fragments of keratin
Michael Zasloff
Georgetown Transplant Institute, Georgetown University School of Medicine, Washington, DC, USA.
In addition to its role in refraction, the cornea forms a barrier between the 
eye and environmental and infectious insults. Corneal infections are sur-
prisingly rare, suggesting that multiple aspects of the immune system are 
at play in mediating protection. In this issue of the JCI, Tam et al. describe 
the unexpected role of a structural protein, cytokeratin 6A, in this process.
The usual healthy appearance of the cornea 
and conjunctivae of the human eye should 
puzzle you. Why is it that this surface 
looks so healthy, most of the time? How is 
it that despite the almost certain diversity 
of microbes that come in contact with it, 
we so rarely see infection, or its associated 
sign, inflammation, evidence of the body’s 
mechanisms that are called forth to fight 
off microorganisms? Lysozyme in tears 
can defend the eye, but organisms that 
inhabit the upper airway, such as Staphy-
lococcus aureus are resistant to this enzyme 
(1), and other antimicrobial systems must 
be at work, because in the various dry-eye 
syndromes, the reduced tear production 
is not associated with frequent bacterial 
infections. More perplexing is the fact that 
a corneal transplant will not necessar-
ily develop infections at the incision or 
around the suture tracks, and antibiotics 
are not necessarily required postoperatively 
(2). Thus, even the wounded cornea seems 
to handle microbes in some mysterious — 
and remarkably effective — fashion.
Layers of protection
The cornea is a wonderful, close-up exam-
ple of a site protected almost completely by 
the chemical and physical defenses of our 
innate immune system. Tears contain high 
concentrations (about 1 to 2 mg/ml) of each 
of three antimicrobial proteins: lysozyme, 
lactoferrin, and lipocalin (3). The presence 
of lactoferrin, which chelates iron, and lipo-
calin, which captures the iron-transporting 
siderophores used by many bacteria, tells 
us that many microbes would discover the 
microenvironment of the corneal epithe-
lium to be unfavorably iron-depleted. The 
corneal epithelium secretes several types of 
mucin that adhere to the corneal surface 
(4) and form a barrier that both provides a 
physical shield from invaders and creates 
an “unstirred” micron-thick fluid layer 
between itself and the corneal epithelial cell. 
Antimicrobial peptides are secreted into this 
barrier and can accumulate without diffu-
sion (or dilution) into to the tear fluids. 
Furthermore, we have known for some time 
that the epithelium expresses several well-
characterized antimicrobial peptides, both 
constitutively and induced following injury 
(5). These include several of the β-defensins 
and LL-37 (cathelicidin), which are believed 
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